Emma Reeve, Director at PTC THERAPEUTICS, INC. (PTCT), sold 15,705 shares at $59.50 ($934K) on 2025-09-11, disclosed to the SEC on 2025-09-16.
Scheduled sale ($934k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.50 | 837 | $50K | 5.3% |
| 2 | $59.50 | 1,334 | $79K | 8.5% |
| 3 | $59.50 | 3,534 | $210K | 22.5% |
| 4 | $59.50 | 10,000 | $595K | 63.7% |
| Total | $59.50 avg | 15,705 | $934K | 100% |
| Filing → |
| PTCT | SELL | 2025-11-25 | $795K | — | Filing → |
| PTCT | SELL | 2025-11-14 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-31 | $1.1M | — | Filing → |